Sanofi-adr (SNY) — Who's Buying and Selling (13F, Q2 2026)

SNY ranks #748 out of 37696 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

SNY is a top-conviction position for Regal Partners Ltd — at 6.3% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in SNY belongs to Dodge & Cox, but the position matters far more to Regal Partners Ltd, who has 6.3% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

Avior Wealth Management, LLC has added to its SNY position for two straight quarters, increasing it by $40.9K to reach $264.4K today.

DAVENPORT & Co LLC has trimmed its SNY position for two straight quarters, cutting it by $18.4M while still holding $81.8M.

SNY is up 0.8% today, but institutions show net selling of $764.9M this quarter — a divergence between today's price move and the underlying institutional flow.

SNY closed its latest fiscal year with net income of $7.9B.

• Profitable — net income of $7.9B in the latest fiscal year
• Net income improved year over year, from $5.6B to $7.9B
• Generated $10.8B in positive operating cash flow
• Liabilities run x equity — a highly leveraged balance sheet worth noting